Omeros Corporation Further Strengthens Its Balance Sheet Through Series of Financing Transactions Extending Maturity on a Majority of Its Outstanding Debt Into 2028
奧麥羅製藥公司通過一系列融資交易進一步加強了其資產負債表,將大部分未償債務的到期期限延長至2028年。
Omeros Corporation Further Strengthens Its Balance Sheet Through Series of Financing Transactions Extending Maturity on a Majority of Its Outstanding Debt Into 2028
奧麥羅製藥公司通過一系列融資交易進一步加強了其資產負債表,將大部分未償債務的到期期限延長至2028年。
譯文內容由第三人軟體翻譯。